OBJECTIVES: The objective of this study was to investigate the effects of acupuncture treatment for symptom management in patients with hyper-immunoglobulin E (IgE) syndrome (HIES). DESIGN: This was a retrospective case series. SETTING/LOCATION: The study was conducted at the The Clinical Research Center of the National Institutes of Health. SUBJECTS: There were 8 adult patients with HIES ages 23-56 with varying symptoms in the study. INTERVENTION: Acupuncture treatments were given from May 29, 2001 to February 17, 2009. OUTCOME MEASURES: Acupuncture treatment efficacy was measured and evaluated using a 0-10 assessment instrument pre- and post-treatment. RESULTS: The 8 patients with HIES suffered from a wide variety of symptoms related to the disease. Acupuncture treatments uniformly decreased the self-reported severity of symptoms. CONCLUSIONS: This case series demonstrates that acupuncture is a clinically useful and safe therapy for symptom management in patients with HIES.
OBJECTIVES: The objective of this study was to investigate the effects of acupuncture treatment for symptom management in patients with hyper-immunoglobulin E (IgE) syndrome (HIES). DESIGN: This was a retrospective case series. SETTING/LOCATION: The study was conducted at the The Clinical Research Center of the National Institutes of Health. SUBJECTS: There were 8 adult patients with HIES ages 23-56 with varying symptoms in the study. INTERVENTION: Acupuncture treatments were given from May 29, 2001 to February 17, 2009. OUTCOME MEASURES: Acupuncture treatment efficacy was measured and evaluated using a 0-10 assessment instrument pre- and post-treatment. RESULTS: The 8 patients with HIES suffered from a wide variety of symptoms related to the disease. Acupuncture treatments uniformly decreased the self-reported severity of symptoms. CONCLUSIONS: This case series demonstrates that acupuncture is a clinically useful and safe therapy for symptom management in patients with HIES.
Authors: F Pfab; J Huss-Marp; A Gatti; J Fuqin; G I Athanasiadis; D Irnich; U Raap; W Schober; H Behrendt; J Ring; U Darsow Journal: Allergy Date: 2009-12-11 Impact factor: 13.146
Authors: Karin R Engelhardt; Sean McGhee; Sabine Winkler; Atfa Sassi; Cristina Woellner; Gabriela Lopez-Herrera; Andrew Chen; Hong Sook Kim; Maria Garcia Lloret; Ilka Schulze; Stephan Ehl; Jens Thiel; Dietmar Pfeifer; Hendrik Veelken; Tim Niehues; Kathrin Siepermann; Sebastian Weinspach; Ismail Reisli; Sevgi Keles; Ferah Genel; Necil Kutukculer; Necil Kutuculer; Yildiz Camcioğlu; Ayper Somer; Elif Karakoc-Aydiner; Isil Barlan; Andrew Gennery; Ayse Metin; Aydan Degerliyurt; Maria C Pietrogrande; Mehdi Yeganeh; Zeina Baz; Salem Al-Tamemi; Christoph Klein; Jennifer M Puck; Steven M Holland; Edward R B McCabe; Bodo Grimbacher; Talal A Chatila Journal: J Allergy Clin Immunol Date: 2009-12 Impact factor: 10.793
Authors: Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su Journal: N Engl J Med Date: 2009-09-23 Impact factor: 91.245
Authors: Wilson S Robinson; Sandra R Arnold; Christie F Michael; John D Vickery; Robert A Schoumacher; Eniko K Pivnick; Jewell C Ward; Vijaya Nagabhushanam; Dukhee B Lew Journal: Clin Mol Allergy Date: 2011-11-29